deltatrials

Secondary hyperparathyroidism Trials in Tokyo, Japan

Conditions / Secondary hyperparathyroidism / Tokyo, Japan

Clinical trials for Secondary hyperparathyroidism investigate a range of treatment strategies and patient populations.

12 total trials for this combination

Showing top 10 of 12 trials

Trials

NCT ID Title Status Phase
NCT02549417 Phase 3 Study of KHK7580 COMPLETED PHASE3
NCT03801980 Phase 3 Study of SK-1403 COMPLETED PHASE3
NCT02143271 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis COMPLETED PHASE1
NCT00701805 Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD) COMPLETED PHASE2
NCT00990704 Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism COMPLETED PHASE2
NCT02549404 Phase 3 Study of KHK7580 COMPLETED PHASE3
NCT02216656 Phase 2 Study of KHK7580 COMPLETED PHASE2
NCT00667576 Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis COMPLETED PHASE2
NCT01341782 Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism COMPLETED PHASE3
NCT02549391 Phase 3 Study of KHK7580 COMPLETED PHASE2/PHASE3

Related Pages